Literature DB >> 25577439

A critical role for transcription factor Smad4 in T cell function that is independent of transforming growth factor β receptor signaling.

Ai-Di Gu1, Song Zhang1, Yunqi Wang1, Hui Xiong1, Thomas A Curtis1, Yisong Y Wan2.   

Abstract

Transforming growth factor-beta (TGF-β) suppresses T cell function to maintain self-tolerance and to promote tumor immune evasion. Yet how Smad4, a transcription factor component of TGF-β signaling, regulates T cell function remains unclear. Here we have demonstrated an essential role for Smad4 in promoting T cell function during autoimmunity and anti-tumor immunity. Smad4 deletion rescued the lethal autoimmunity resulting from transforming growth factor-beta receptor (TGF-βR) deletion and compromised T-cell-mediated tumor rejection. Although Smad4 was dispensable for T cell generation, homeostasis, and effector function, it was essential for T cell proliferation after activation in vitro and in vivo. The transcription factor Myc was identified to mediate Smad4-controlled T cell proliferation. This study thus reveals a requirement of Smad4 for T-cell-mediated autoimmunity and tumor rejection, which is beyond the current paradigm. It highlights a TGF-βR-independent role for Smad4 in promoting T cell function, autoimmunity, and anti-tumor immunity.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25577439      PMCID: PMC4303504          DOI: 10.1016/j.immuni.2014.12.019

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  47 in total

Review 1.  TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression.

Authors:  Li Yang; Yanli Pang; Harold L Moses
Journal:  Trends Immunol       Date:  2010-06-01       Impact factor: 16.687

2.  Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development.

Authors:  Tomohito Takimoto; Yu Wakabayashi; Takashi Sekiya; Naoko Inoue; Rimpei Morita; Kenji Ichiyama; Reiko Takahashi; Mayako Asakawa; Go Muto; Tomoaki Mori; Eiichi Hasegawa; Shizuya Saika; Saika Shizuya; Toshiro Hara; Masatoshi Nomura; Akihiko Yoshimura
Journal:  J Immunol       Date:  2010-06-14       Impact factor: 5.422

Review 3.  WNT signalling in the immune system: WNT is spreading its wings.

Authors:  Frank J T Staal; Tiago C Luis; Machteld M Tiemessen
Journal:  Nat Rev Immunol       Date:  2008-08       Impact factor: 53.106

4.  SnapShot: The TGFbeta pathway interactome.

Authors:  Ian W Taylor; Jeffrey L Wrana
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582

5.  Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.

Authors:  Li Yang; Jianhua Huang; Xiubao Ren; Agnieszka E Gorska; Anna Chytil; Mary Aakre; David P Carbone; Lynn M Matrisian; Ann Richmond; P Charles Lin; Harold L Moses
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

6.  Molecular antagonism and plasticity of regulatory and inflammatory T cell programs.

Authors:  Xuexian O Yang; Roza Nurieva; Gustavo J Martinez; Hong Soon Kang; Yeonseok Chung; Bhanu P Pappu; Bhavin Shah; Seon Hee Chang; Kimberly S Schluns; Stephanie S Watowich; Xin-Hua Feng; Anton M Jetten; Chen Dong
Journal:  Immunity       Date:  2008-06-26       Impact factor: 31.745

7.  A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells.

Authors:  Yongzhong Liu; Pin Zhang; Jun Li; Ashok B Kulkarni; Sylvain Perruche; Wanjun Chen
Journal:  Nat Immunol       Date:  2008-04-27       Impact factor: 25.606

8.  Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.

Authors:  Zvi G Fridlender; Jing Sun; Samuel Kim; Veena Kapoor; Guanjun Cheng; Leona Ling; G Scott Worthen; Steven M Albelda
Journal:  Cancer Cell       Date:  2009-09-08       Impact factor: 31.743

Review 9.  TGFbeta signalling in control of T-cell-mediated self-reactivity.

Authors:  Yuri P Rubtsov; Alexander Y Rudensky
Journal:  Nat Rev Immunol       Date:  2007-06       Impact factor: 53.106

10.  Control of the development of CD8αα+ intestinal intraepithelial lymphocytes by TGF-β.

Authors:  Joanne E Konkel; Takashi Maruyama; Andrea C Carpenter; Yumei Xiong; Brian F Zamarron; Bradford E Hall; Ashok B Kulkarni; Pin Zhang; Remy Bosselut; WanJun Chen
Journal:  Nat Immunol       Date:  2011-02-06       Impact factor: 25.606

View more
  23 in total

Review 1.  Tissue-Specific Control of Tissue-Resident Memory T Cells.

Authors:  Yong Liu; Chaoyu Ma; Nu Zhang
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

2.  SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-β signaling.

Authors:  Victor S Cortez; Tyler K Ulland; Luisa Cervantes-Barragan; Jennifer K Bando; Michelle L Robinette; Qianli Wang; Andrew J White; Susan Gilfillan; Marina Cella; Marco Colonna
Journal:  Nat Immunol       Date:  2017-07-31       Impact factor: 25.606

Review 3.  Environmental cues orchestrate regional immune surveillance and protection by pulmonary CTLs.

Authors:  Linda S Cauley
Journal:  J Leukoc Biol       Date:  2016-06-17       Impact factor: 4.962

4.  New traffic light on Th17 Avenue.

Authors:  Hao Xu; Dan R Littman
Journal:  Cell Res       Date:  2017-12-08       Impact factor: 25.617

5.  Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.

Authors:  Shelli M Morris; Jerry Davison; Kelly T Carter; Rachele M O'Leary; Patty Trobridge; Sue E Knoblaugh; Lois L Myeroff; Sanford D Markowitz; Benjamin T Brett; Todd E Scheetz; Adam J Dupuy; Timothy K Starr; William M Grady
Journal:  Int J Cancer       Date:  2016-11-07       Impact factor: 7.396

Review 6.  The role of transforming growth factor β in T helper 17 differentiation.

Authors:  Song Zhang
Journal:  Immunology       Date:  2018-05-08       Impact factor: 7.397

7.  TGF-β receptor maintains CD4 T helper cell identity during chronic viral infections.

Authors:  Gavin M Lewis; Ellen J Wehrens; Lara Labarta-Bajo; Hendrik Streeck; Elina I Zuniga
Journal:  J Clin Invest       Date:  2016-09-06       Impact factor: 14.808

8.  Potentiating tumor immunity using aptamer-targeted RNAi to render CD8+ T cells resistant to TGFβ inhibition.

Authors:  Yvonne Puplampu-Dove; Tal Gefen; Anugraha Rajagopalan; Darija Muheramagic; Brett Schrand; Eli Gilboa
Journal:  Oncoimmunology       Date:  2018-02-15       Impact factor: 8.110

9.  SMAD4 promotes TGF-β-independent NK cell homeostasis and maturation and antitumor immunity.

Authors:  Youwei Wang; Jianhong Chu; Ping Yi; Wenjuan Dong; Jennifer Saultz; Yufeng Wang; Hongwei Wang; Steven Scoville; Jianying Zhang; Lai-Chu Wu; Youcai Deng; Xiaoming He; Bethany Mundy-Bosse; Aharon G Freud; Li-Shu Wang; Michael A Caligiuri; Jianhua Yu
Journal:  J Clin Invest       Date:  2018-10-15       Impact factor: 14.808

10.  SMAD4 TGF-β-independent function preconditions naive CD8+ T cells to prevent severe chronic intestinal inflammation.

Authors:  Ramdane Igalouzene; Hector Hernandez-Vargas; Nicolas Benech; Alexandre Guyennon; David Bauché; Célia Barrachina; Emeric Dubois; Julien C Marie; Saïdi M'Homa Soudja
Journal:  J Clin Invest       Date:  2022-04-15       Impact factor: 19.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.